share_log

GSK Says Depemokimab Results Show 54% Decrease in Severe Asthma Exacerbations

GSK Says Depemokimab Results Show 54% Decrease in Severe Asthma Exacerbations

葛蘭素史克表示,Depemokimab的結果顯示嚴重哮喘發作減少了54%
MT Newswires ·  09/09 10:24

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論